Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
Metabolic reprogramming is an emerging hallmark of tumor cells. In order to survive in the nutrient-deprived environment, tumor cells rewire their metabolic phenotype to provide sufficient energy and build biomass to sustain their transformed state and promote malignant behaviors. Amino acids are th...
Main Authors: | Naihui Sun, Xing Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.935553/full |
Similar Items
-
Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression
by: Anke Werner, et al.
Published: (2017-07-01) -
The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
by: Niramol Savaraj, et al.
Published: (2007-01-01) -
Targeting RNA‐binding motif protein 39 for arginine reduction: unveiling metabolic vulnerability in arginine‐dependent liver cancer
by: Aoxue Li, et al.
Published: (2024-07-01) -
Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
by: Xiaoshuang Hou, et al.
Published: (2022-07-01) -
Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer
by: Naihui Sun, et al.
Published: (2022-07-01)